Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021051 (
immunodeficiency
)
71,517
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The control of cytoskeletal dynamics by
dedicator of cytokinesis 2
(
DOCK2
), a hematopoietic cell-specific actin effector protein, has been implicated in TCR signaling and T cell migration. Biallelic mutations in
Dock2
have been identified in patients with a recessive form of combined
immunodeficiency
with defects in T, B, and NK cell activation. Surprisingly, we show in this study that certain immune functions of CD8
+
T cells are enhanced in the absence of
DOCK2
.
Dock2
-deficient mice have a pronounced expansion of their memory T cell compartment. Bone marrow chimera and adoptive transfer studies indicate that these memory T cells develop in a cell-intrinsic manner following thymic egress. Transcriptional profiling, TCR repertoire analyses, and cell surface marker expression indicate that
Dock2
-deficient naive CD8
+
T cells directly convert into virtual memory cells without clonal effector T cell expansion. This direct conversion to memory is associated with a selective increase in TCR sensitivity to self-peptide MHC in vivo and an enhanced response to weak agonist peptides ex vivo. In contrast, the response to strong agonist peptides remains unaltered in
Dock2
-deficient T cells. Collectively, these findings suggest that the regulation of the actin dynamics by
DOCK2
enhances the threshold for entry into the virtual memory compartment by negatively regulating tonic TCR triggering in response to weak agonists.
...
PMID:DOCK2 Sets the Threshold for Entry into the Virtual Memory CD8
+
T Cell Compartment by Negatively Regulating Tonic TCR Triggering. 3174 Apr 87